Cardiovia
1 known investors
CardioVia develops ViaOne, an FDA-cleared epicardial access device that creates a pathway to the heart's surface using a blunt tip with a concealed needle to reduce heart perforation risk. The device supports cardiac interventions such as arrhythmia ablation, epicardial lead and pacemaker implantation, and targeted drug, stem cell, and gene delivery.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Cardiovia do?
- CardioVia develops ViaOne, an FDA-cleared epicardial access device that creates a pathway to the heart's surface using a blunt tip with a concealed needle to reduce heart perforation risk. The device supports cardiac interventions such as arrhythmia ablation, epicardial lead and pacemaker implantation, and targeted drug, stem cell, and gene delivery.
- Who founded Cardiovia?
- Cardiovia was founded by Ziv Menshes, Or Hazan.
- Who are Cardiovia's investors?
- Cardiovia's investors include NGT Healthcare 2.